

What is Afrezza? Learn about this inhaled insulin — its uses, dosing, how it works, who it's for, and important safety info for 2026.
Afrezza is an FDA-approved inhaled insulin used to improve blood sugar control in adults with type 1 diabetes and type 2 diabetes. Unlike traditional insulins that you inject with a needle or pen, Afrezza is a dry powder that you breathe into your lungs using a small, pocket-sized inhaler.
Afrezza is made by MannKind Corporation and is the only inhaled insulin currently available in the United States. It is a rapid-acting insulin, meaning it works quickly to help manage blood sugar spikes that happen after meals.
The biggest difference is the delivery method. Instead of injecting insulin under your skin, you inhale a fine powder through a small device called the Afrezza Inhaler. This makes it an attractive option for people who:
However, Afrezza is not a replacement for long-acting (basal) insulin. If you have type 1 diabetes, you still need a basal insulin like Lantus, Basaglar, or Tresiba in addition to Afrezza. For type 2 diabetes, your doctor will determine whether Afrezza alone or in combination with other medications is right for you.
Afrezza is approved to improve glycemic control in adults with:
Afrezza is taken at the beginning of each meal. It helps your body use the sugar from the food you eat, preventing blood sugar spikes after eating.
The Afrezza 180 Titration Pack contains a combination of single-use cartridges in different strengths (4-unit, 8-unit, and 12-unit cartridges). The "60, 60, 60" refers to the cartridge count breakdown in the pack. This titration pack is designed for patients who are starting Afrezza or adjusting their dose, allowing them to try different strengths to find the right mealtime dose.
Your doctor will determine your dose based on your individual needs. Here are the general guidelines:
Each cartridge is used for a single inhalation. The inhaler device itself should be replaced every 15 days.
Using Afrezza is straightforward:
Take Afrezza at the beginning of your meal. Because it works fast, timing it right helps it match your blood sugar rise from eating.
For a deeper explanation of how the drug works in your body, see How Does Afrezza Work? Mechanism of Action Explained.
Afrezza has a boxed warning — the FDA's most serious type of warning — about the risk of acute bronchospasm in patients with chronic lung disease. Afrezza is contraindicated (must not be used) in patients with:
A spirometry test (lung function test) is required before starting Afrezza to make sure your lungs are healthy enough for the medication.
The most common side effects include cough, sore throat, hypoglycemia, headache, diarrhea, and fatigue. For a complete breakdown, read our guide: Afrezza Side Effects: What to Expect and When to Call Your Doctor.
Afrezza is a brand-name medication with no generic available. The cash price typically ranges from $550 to $650 per prescription. Many insurance plans cover Afrezza but may require prior authorization or step therapy (trying injectable insulin first).
MannKind offers a savings program through AfrezzaAssist. For more ways to reduce costs, see How to Save Money on Afrezza.
Because Afrezza is made by a single manufacturer and is not widely stocked at retail pharmacies, it can sometimes be hard to find. If you are having trouble locating it, try these resources:
Afrezza can interact with several other medications, including beta-blockers, ACE inhibitors, corticosteroids, and other diabetes drugs. Always tell your doctor about all medications you take. For a full list, see Afrezza Drug Interactions: What to Avoid.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.